Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diego Kauffmann-Guerrero

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
Translational Lung Cancer Research|September 21, 2020
Adjuvant TKI treatment of EGFR-mutant lung cancer-already ripe for decision?Diego Kauffmann-Guerrero
Current Opinion in Oncology|November 23, 2021
Rare driver alterations in nonsmall cell lung cancer: novel targeted drugsDiego Kauffmann-Guerrero, Amanda Tufman
Translational Lung Cancer Research|April 18, 2025
Will INSPIRE crown iruplinalkib as a new standard choice in first-line advanced <i>ALK</i>-positive non-small cell lung cancer?Blerina Resuli, Diego Kauffmann-Guerrero
Current Opinion in Oncology|November 11, 2024
Novel immunotherapeutic approaches in lung cancer: driving beyond programmed death-1/programmed death ligand-1 and cytotoxic T-lymphocyte-associated Protein-4Blerina Resuli, Diego Kauffmann-Guerrero
Lung Cancer (Auckland, N.Z.)|March 19, 2020
Orphan Drugs in Development for the Treatment of Small-Cell Lung Cancer: Emerging Data on LurbinectedinDiego Kauffmann-Guerrero, Rudolf Maria Huber
Current Opinion in Oncology|November 11, 2024
Immune checkpoint inhibitors in driver mutation-positive nonsmall cell lung cancerRudolf M Huber, Diego Kauffmann-Guerrero
Drugs|May 26, 2021
Correction to: Treatment Sequencing for Anaplastic Lymphoma Kinase-Rearranged Non-Small-Cell Lung CancerDiego Kauffmann-Guerrero, Kathrin Kahnert, Rudolf M Huber
Clinical Lung Cancer|July 12, 2016
SCLC-State of the Art and What Does the Future Have in Store?Kathrin Kahnert, Diego Kauffmann-Guerrero, Rudolf Maria Huber
Drugs|November 23, 2020
Treatment Sequencing for Anaplastic Lymphoma Kinase-Rearranged Non-Small-Cell Lung CancerDiego Kauffmann-Guerrero, Kathrin Kahnert, Rudolf M Huber
JTO Clinical and Research Reports|November 13, 2024
Simultaneous Occurrence of <i>HER2</i> Mutations in <i>EGFR</i> Mutant NSCLC: Case ReportsBlerina Resuli, Diego Kauffmann-Guerrero, Jürgen Behr, et al.
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
Translational Lung Cancer Research|September 21, 2020
Adjuvant TKI treatment of EGFR-mutant lung cancer-already ripe for decision?Diego Kauffmann-Guerrero
Current Opinion in Oncology|November 23, 2021
Rare driver alterations in nonsmall cell lung cancer: novel targeted drugsDiego Kauffmann-Guerrero, Amanda Tufman
Translational Lung Cancer Research|April 18, 2025
Will INSPIRE crown iruplinalkib as a new standard choice in first-line advanced <i>ALK</i>-positive non-small cell lung cancer?Blerina Resuli, Diego Kauffmann-Guerrero
Current Opinion in Oncology|November 11, 2024
Novel immunotherapeutic approaches in lung cancer: driving beyond programmed death-1/programmed death ligand-1 and cytotoxic T-lymphocyte-associated Protein-4Blerina Resuli, Diego Kauffmann-Guerrero
Lung Cancer (Auckland, N.Z.)|March 19, 2020
Orphan Drugs in Development for the Treatment of Small-Cell Lung Cancer: Emerging Data on LurbinectedinDiego Kauffmann-Guerrero, Rudolf Maria Huber
Current Opinion in Oncology|November 11, 2024
Immune checkpoint inhibitors in driver mutation-positive nonsmall cell lung cancerRudolf M Huber, Diego Kauffmann-Guerrero
Drugs|May 26, 2021
Correction to: Treatment Sequencing for Anaplastic Lymphoma Kinase-Rearranged Non-Small-Cell Lung CancerDiego Kauffmann-Guerrero, Kathrin Kahnert, Rudolf M Huber
Clinical Lung Cancer|July 12, 2016
SCLC-State of the Art and What Does the Future Have in Store?Kathrin Kahnert, Diego Kauffmann-Guerrero, Rudolf Maria Huber
Drugs|November 23, 2020
Treatment Sequencing for Anaplastic Lymphoma Kinase-Rearranged Non-Small-Cell Lung CancerDiego Kauffmann-Guerrero, Kathrin Kahnert, Rudolf M Huber
JTO Clinical and Research Reports|November 13, 2024
Simultaneous Occurrence of <i>HER2</i> Mutations in <i>EGFR</i> Mutant NSCLC: Case ReportsBlerina Resuli, Diego Kauffmann-Guerrero, Jürgen Behr, et al.
Pageof 9